The pediatric cancer program is part of the Duke
Comprehensive Cancer Center. One of only 40 centers in the
country designated by the National Cancer Institute (NCI) as a
“comprehensive cancer center,” Duke combines cutting-edge
research with compassionate care.
Research
Within the Duke Comprehensive Cancer Center there is ongoing
research into many different aspects of childhood cancer and
its treatment, including:
- The use of unrelated umbilical cord blood to treat
resistant cancers as well as immune deficiencies and rare
metabolic diseases for which there is no other cure.
- Lifestyle change interventions to improve health in
cancer survivors
- Fertility preservation in cancer patients
- Psychological issues in children and families dealing
with chronic illness
- Cancer genetics and genomics
- Experimental therapeutics
- Clinical trials studying novel treatments for pediatric
cancers including leukemias, lymphoma, neuroblastoma, and
embryonal tumors and bone and muscle tumors.
Each new discovery is brought rapidly into the clinic where
doctors work to provide patients with the most promising
therapies available.
